fexofenadine has been researched along with Aggressive Systemic Mastocytosis in 1 studies
fexofenadine: a second generation antihistamine; metabolite of the antihistaminic drug terfenadine; structure in first source; RN refers to HCl
fexofenadine : A piperidine-based anti-histamine compound.
Aggressive Systemic Mastocytosis: A form of systemic mastocytosis in which patients have impaired organ functions due to multifocal infiltrates of pathological MAST CELLS in bone marrow, liver, spleen, gastrointestinal tract, or skeletal system. The cytomorphology shows a low to high grade.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Urolithiasis is expected to cause a considerable complication in patients with systemic mastocytosis." | 1.35 | Ureteral stones due to systemic mastocytosis: diagnostic and therapeutic characteristics. ( Homann, J; Kolck, UW; Molderings, GJ; Schröder, D; Solleder, G; von Kügelgen, I; Vorreuther, R, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Molderings, GJ | 1 |
| Solleder, G | 1 |
| Kolck, UW | 1 |
| Homann, J | 1 |
| Schröder, D | 1 |
| von Kügelgen, I | 1 |
| Vorreuther, R | 1 |
1 other study available for fexofenadine and Aggressive Systemic Mastocytosis
| Article | Year |
|---|---|
Ureteral stones due to systemic mastocytosis: diagnostic and therapeutic characteristics.
Topics: Diagnosis, Differential; Glucocorticoids; Histamine H1 Antagonists, Non-Sedating; Histamine H2 Antag | 2009 |